Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
+$0.07 today
- Market cap
- $332.70M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
Volume 0.26M
Average 0.26M
VMD Account Payables
Amounts the company owes suppliers for goods and services received.
Viemed Healthcare, Inc.NASDAQ: VMD
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 6.0% from a year ago
Account payables stood at $13.39M at the end of Q1 FY2026, up 6.0% from a year earlier and up 8.6% from the prior quarter. Over 3 fiscal years it compounded at +36.0% a year.
Context
- Account payables amounted to 6.8% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Account payables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +6.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 12.33M USD
- Year-over-year change
- +32.0%
- 4-year CAGR
- +23.8%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.33M | +32.0% |
| FY2024 | 2024-12-31 | 9.34M | +26.0% |
| FY2023 | 2023-12-31 | 7.41M | +51.1% |
| FY2022 | 2022-12-31 | 4.9M | -6.6% |
| FY2021 | 2021-12-31 | 5.25M | — |
Account Payables vs competitors
How VMD compares with its peers on the latest reported figures
- VMD's Mar 2026 account payables of $13.39M is the 2nd highest of the 11 companies compared; the peer median is $2.94M.
- Its year-over-year change of +6.0% is the 8th highest of 11, against a peer median of +25.7%.
- Account payables amounts to 6.8% of total assets for VMD, versus a peer median of 2.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $31.3M | +34.6% | +3.6% | 10.9% | |
| Mar 2026 | $13.39M | +6.0% | +36.0% | 6.8% | |
| Mar 2026 | $8.66M | +28.6% | +52.4% | 2.4% | |
| Mar 2026 | $3.32M | -20.0% | -9.9% | 8.9% | |
| Mar 2026 | $3.19M | +58.8% | +113.2% | 3.1% | |
| Mar 2026 | $3M | +9.0% | +30.6% | 3.0% | |
| Dec 2025 | $2.89M | +30.6% | -7.3% | 1.8% | |
| Mar 2026 | $2.6M | +38.1% | +28.4% | 4.4% | |
| Mar 2026 | $2.42M | -37.2% | +82.0% | 1.3% | |
| Mar 2026 | $1.49M | -46.3% | -20.6% | 1.4% | |
| Mar 2026 | $1.44M | +22.9% | -2.8% | 0.6% | |
| Peer median (excluding VMD) | $2.94M | +25.7% | +16.0% | 2.7% | |
Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.41M | 16.91M | 12.84M | 17.54M | 13.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.72M | 15.41M | 18.45M | 24.91M | 25.59M |
| Inventory | 2.46M | 3.57M | 4.63M | 4.32M | 5.05M |
| Other Current Assets | 0 | 3.85M | 2.45M | 6.11M | 4.36M |
| Total Current Assets | 47.31M | 39.74M | 38.37M | 52.88M | 48.49M |
| Property, Plant & Equipment (Net) | 62.85M | 68.44M | 76.85M | 79.16M | 82.36M |
| Goodwill | 0 | 0 | 29.77M | 32.99M | 58.94M |
| Intangible Assets | 0 | 0 | 567K | 848K | 1.29M |
| Long-term Investments | 2.16M | 4.16M | 3.9M | 2.79M | 2.79M |
| Tax Assets | 4.79M | 3.12M | 4.56M | 8.4M | 5.29M |
| Other Non-current Assets | 862K | 1.59M | 887K | 0 | 15.79M |
| Total Non-current Assets | 70.65M | 77.3M | 116.53M | 124.19M | 166.45M |
| Total Assets | 117.96M | 117.04M | 154.9M | 177.07M | 214.94M |
| Account Payables | 5.25M | 4.9M | 7.41M | 9.34M | 12.33M |
| Short-term Debt | 1.48M | 0 | 1.07M | 409K | 1.09M |
| Tax Payables | 0 | 0 | 2.15M | 3.88M | 0 |
| Deferred Revenue | 3.75M | 4.62M | 6.21M | 6.69M | 7.52M |
| Other Current Liabilities | 2.34M | 3.19M | 6.52M | 5.1M | 6.3M |
| Total Current Liabilities | 17.81M | 18.86M | 32.12M | 37.33M | 41.06M |
| Long-term Debt | 4.31M | 0 | 6M | 3.59M | 11.29M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 15.79M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 757K | 889K | 558K | 846K | 922K |
| Total Non-current Liabilities | 5.33M | 1.09M | 8.88M | 6.44M | 30.37M |
| Total Liabilities | 23.14M | 19.95M | 41M | 43.77M | 71.42M |
| Common Stock | 14.01M | 15.12M | 18.7M | 23.37M | 16.91M |
| Retained Earnings | 73.34M | 69.85M | 79.5M | 89.69M | 102.89M |
| Accumulated OCI | (278K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 1.91M | 1.98M |
| Total Equity | 94.82M | 97.09M | 113.9M | 133.3M | 143.52M |
| Total Debt | 6.52M | 694K | 10.32M | 6.87M | 15.95M |
| Net Debt | (21.89M) | (16.22M) | (2.52M) | (10.67M) | 2.45M |
Viemed Healthcare, Inc.
NASDAQ:VMD
Intrinsic Alpha fair value
Locked
Current Price
$8.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.